
AxoGen AXGN
$ 33.35
2.25%
Quarterly report 2025-Q2
added 08-05-2025
AxoGen ROE Ratio 2011-2026 | AXGN
Annual ROE Ratio AxoGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.59 | -22.7 | -28.66 | -23.98 | -19.31 | -22.05 | -15.24 | -41.48 | -96.58 | -162.97 | 157.49 | -10654.0 | 332.86 | -151.84 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 332.86 | -10654.0 | -768.43 |
Quarterly ROE Ratio AxoGen
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.86 | -9.38 | -11.0 | -15.18 | -17.49 | -22.34 | -18.29 | -22.55 | -22.62 | -23.38 | -22.92 | -29.11 | -31.05 | -30.09 | -18.41 | -23.29 | -18.3 | -18.23 | -19.31 | -19.76 | -22.77 | -21.51 | -22.05 | -20.27 | -18.85 | -18.59 | -15.24 | -21.61 | -27.25 | -30.38 | -41.48 | -69.27 | -76.28 | -86.88 | -96.58 | -95.22 | -116.11 | -136.26 | -118.9 | -90.11 | -24.97 | 47.24 | 99.76 | -2500.47 | -5129.5 | -7693.49 | -7646.83 | -7567.77 | -4888.48 | -2321.37 | 190.0 | 138.72 | 8.39 | -55.64 | -116.65 | -51.28 | -27.63 | -37.74 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 190.0 | -7693.49 | -674.53 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
-10.47 | - | - | $ 3.31 B | ||
|
Acutus Medical
AFIB
|
9290.44 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-264.39 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
97.55 | - | 1.37 % | $ 20.5 M | ||
|
Cognyte Software Ltd.
CGNT
|
-6.08 | $ 7.09 | 3.2 % | $ 509 M | ||
|
Apyx Medical Corporation
APYX
|
-70.08 | $ 3.85 | 0.79 % | $ 133 M | ||
|
Alphatec Holdings
ATEC
|
1144.21 | $ 13.41 | 2.33 % | $ 1.92 B | ||
|
BIOLASE
BIOL
|
8353.04 | - | -13.19 % | $ 166 K | ||
|
Bio-Rad Laboratories
BIO
|
-10.9 | $ 259.84 | -10.91 % | $ 7.33 B | ||
|
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
6.35 | $ 36.2 | -3.51 % | $ 5.39 K | ||
|
BioSig Technologies
BSGM
|
669.04 | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
13.76 | $ 42.01 | 0.74 % | $ 1.3 B | ||
|
Boston Scientific Corporation
BSX
|
8.48 | $ 75.35 | 1.66 % | $ 111 B | ||
|
Abbott Laboratories
ABT
|
28.12 | $ 112.29 | 0.73 % | $ 195 B | ||
|
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | ||
|
Delcath Systems
DCTH
|
-38.38 | $ 9.37 | 2.74 % | $ 267 M | ||
|
Cutera
CUTR
|
33.31 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
-46.5 | $ 4.79 | 0.42 % | $ 179 M | ||
|
ClearPoint Neuro
CLPT
|
-74.5 | $ 13.81 | 5.9 % | $ 373 M | ||
|
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | ||
|
Electromed
ELMD
|
17.44 | $ 23.82 | 2.21 % | $ 201 M | ||
|
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-1451.06 | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | ||
|
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | ||
|
Inogen
INGN
|
-20.64 | $ 5.88 | 1.52 % | $ 139 M | ||
|
InMode Ltd.
INMD
|
25.76 | $ 14.32 | 0.14 % | $ 1.14 B | ||
|
GBS
GBS
|
-352.75 | - | -0.57 % | $ 7.12 M | ||
|
IRadimed Corporation
IRMD
|
22.15 | $ 101.26 | 1.42 % | $ 1.28 B | ||
|
Integer Holdings Corporation
ITGR
|
7.4 | $ 85.84 | 0.68 % | $ 2.88 B | ||
|
Second Sight Medical Products
EYES
|
-133.37 | - | -0.97 % | $ 54.4 M | ||
|
Penumbra
PEN
|
1.22 | $ 340.3 | 0.46 % | $ 13.1 B | ||
|
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
8.28 | $ 18.54 | - | $ 122 M | ||
|
Globus Medical
GMED
|
2.47 | $ 89.17 | 2.24 % | $ 12.1 B | ||
|
Pulmonx Corporation
LUNG
|
-65.72 | $ 1.49 | 4.93 % | $ 58.3 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
-0.45 | $ 11.52 | 6.57 % | $ 887 M | ||
|
Myomo
MYO
|
-168.59 | $ 0.81 | 1.15 % | $ 5.71 M | ||
|
Establishment Labs Holdings
ESTA
|
-159.33 | $ 72.85 | -0.94 % | $ 2.05 B |